Treatment of neuroleptic malignant syndrome with levodopa
- 1 May 1992
- journal article
- case report
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 7 (3) , 217-221
- https://doi.org/10.1002/hup.470070310
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Crossover reaction between haloperidol and amoxapine for NMSThe British Journal of Psychiatry, 1991
- The Treatment of Neuroleptic Malignant Syndrome are Dantrolene and Bromocriptine Useful Adjuncts to Supportive Care?The British Journal of Psychiatry, 1991
- NMS and genetic drug oxidationThe British Journal of Psychiatry, 1991
- Is the Predisposition to Neuroleptic Malignant Syndrome Genetically Transmitted?The British Journal of Psychiatry, 1991
- Pharmacotherapy of Neuroleptic Malignant SyndromePsychiatric Annals, 1991
- The (Frequently) Neuroleptic (Potentially) Malignant SyndromeThe British Journal of Psychiatry, 1990
- Neuroleptic Malignant SyndromeArchives of internal medicine (1960), 1989
- Neuroleptic Malignant Syndrome Responsive to Carbidopa/LevodopaClinical Neuropharmacology, 1987
- Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospitalAmerican Journal of Psychiatry, 1986
- Neuroleptic Malignant SyndromeClinical Neuropharmacology, 1984